These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 23540692)
21. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model. Neuhaus W; Freidl M; Szkokan P; Berger M; Wirth M; Winkler J; Gabor F; Pifl C; Noe CR Brain Res; 2011 Jun; 1394():49-61. PubMed ID: 21549356 [TBL] [Abstract][Full Text] [Related]
22. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors). Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233 [TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment. Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422 [TBL] [Abstract][Full Text] [Related]
25. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
26. Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior. Liu M; Imam H; Oberg K; Zhou Y Neuroendocrinology; 2005; 82(1):1-10. PubMed ID: 16293970 [TBL] [Abstract][Full Text] [Related]
27. NMDA Receptor and Its Emerging Role in Cancer. Gallo S; Vitacolonna A; Crepaldi T Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768862 [TBL] [Abstract][Full Text] [Related]
28. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Fujisawa T; Joshi B; Nakajima A; Puri RK Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609 [TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation. Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804 [TBL] [Abstract][Full Text] [Related]
30. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling. Leu FP; Nandi M; Niu C Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806 [TBL] [Abstract][Full Text] [Related]
31. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate. D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111 [TBL] [Abstract][Full Text] [Related]
32. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641 [TBL] [Abstract][Full Text] [Related]
33. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer. Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761 [TBL] [Abstract][Full Text] [Related]
34. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis. Shchors K; Nozawa H; Xu J; Rostker F; Swigart-Brown L; Evan G; Hanahan D Oncogene; 2013 Jan; 32(4):502-13. PubMed ID: 22391572 [TBL] [Abstract][Full Text] [Related]
35. Animal models and cell lines of pancreatic neuroendocrine tumors. Babu V; Paul N; Yu R Pancreas; 2013 Aug; 42(6):912-23. PubMed ID: 23851429 [TBL] [Abstract][Full Text] [Related]
36. The influence of glutamate receptors on proliferation and metabolic cell activity of neuroendocrine tumors. Haas HS; Pfragner R; Tabrizi-Wizsy NG; Rohrer K; Lueftenegger I; Horwath C; Allard N; Rinner B; Sadjak A Anticancer Res; 2013 Apr; 33(4):1267-72. PubMed ID: 23564764 [TBL] [Abstract][Full Text] [Related]
37. Autocrine glutamatergic transmission for the regulation of embryonal carcinoma stem cells. Teng L; Lei HM; Sun F; An SM; Tang YB; Meng S; Wang CH; Shen Y; Chen HZ; Zhu L Oncotarget; 2016 Aug; 7(31):49552-49564. PubMed ID: 27322683 [TBL] [Abstract][Full Text] [Related]
39. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Ippolito JE; Xu J; Jain S; Moulder K; Mennerick S; Crowley JR; Townsend RR; Gordon JI Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9901-6. PubMed ID: 15998737 [TBL] [Abstract][Full Text] [Related]
40. Combined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitro. He M; Luo M; Chen S; Li K; Zheng M; Weng Y; Pi R; Liu A Int J Clin Exp Med; 2015; 8(10):18434-40. PubMed ID: 26770449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]